Physiomics Plc (LON:PYC – Get Free Report)’s share price traded down 12.8% during mid-day trading on Wednesday . The stock traded as low as GBX 0.46 and last traded at GBX 0.46. Approximately 1,043,813 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 7,213,239 shares. The stock had previously closed at GBX 0.53.
Physiomics Stock Performance
The business’s 50 day moving average price is GBX 0.55 and its 200-day moving average price is GBX 0.45. The company has a market cap of £2.08 million, a price-to-earnings ratio of -3.05 and a beta of 1.02.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Read More
- Five stocks we like better than Physiomics
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
- EVs Are Big Winners of the Iran War—Just Not American Ones
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
